Literature DB >> 32868753

What can we learn from the failure of quantitative sensory testing?

Martin Schmelz1.   

Abstract

Mesh：

Year:  2021        PMID： 32868753     DOI： 10.1097/j.pain.0000000000002059

Source DB:  PubMed          Journal:  Pain        ISSN： 0304-3959            Impact factor:   6.961


× No keyword cloud information.
  5 in total

1.  Migraine disability, pain catastrophizing, and headache severity are associated with evoked pain and targeted by mind-body therapy.

Authors:  Samuel R Krimmel; Michael L Keaser; Darrah Speis; Jennifer A Haythornthwaite; David A Seminowicz
Journal:  Pain       Date:  2022-01-17       Impact factor: 7.926

Review 2.  Innovations and advances in modelling and measuring pain in animals.

Authors:  Katelyn E Sadler; Jeffrey S Mogil; Cheryl L Stucky
Journal:  Nat Rev Neurosci       Date:  2021-11-26       Impact factor: 38.755

3.  Classification of Qualitative Fieldnotes Collected During Quantitative Sensory Testing: A Step Towards the Development of a New Mixed Methods Approach in Pain Research.

Authors:  Martine Bordeleau; Guillaume Léonard; Lynn Gauthier; Catherine Estelle Ferland; Miroslav Backonja; Jan Vollert; Serge Marchand; Philip Jackson; Léo Cantin; Michel Prud'Homme
Journal:  J Pain Res       Date:  2021-08-18       Impact factor: 3.133

Review 4.  Early Detection of Diabetic Peripheral Neuropathy: A Focus on Small Nerve Fibres.

Authors:  Jamie Burgess; Bernhard Frank; Andrew Marshall; Rashaad S Khalil; Georgios Ponirakis; Ioannis N Petropoulos; Daniel J Cuthbertson; Rayaz A Malik; Uazman Alam
Journal:  Diagnostics (Basel)       Date:  2021-01-24

Review 5.  Cannabis-Based Medicines and Medical Cannabis for Chronic Neuropathic Pain.

Authors:  Frank Petzke; Thomas Tölle; Mary-Ann Fitzcharles; Winfried Häuser
Journal:  CNS Drugs       Date:  2021-11-21       Impact factor: 5.749
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.